Source:http://linkedlifedata.com/resource/pubmed/id/16778303
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2006-6-16
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0971-5916
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
123
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
195-6
|
pubmed:meshHeading |
pubmed-meshheading:16778303-Antiprotozoal Agents,
pubmed-meshheading:16778303-Communicable Disease Control,
pubmed-meshheading:16778303-HIV Infections,
pubmed-meshheading:16778303-Humans,
pubmed-meshheading:16778303-India,
pubmed-meshheading:16778303-Leishmaniasis, Visceral,
pubmed-meshheading:16778303-Public Health
|
pubmed:year |
2006
|
pubmed:articleTitle |
Elimination of leishmaniasis (kala-azar) from the Indian subcontinent is technically feasible & operationally achievable.
|
pubmed:publicationType |
Editorial
|